Paediatric drug development - Historical background of regulatory initiatives

Guide to Paediatric Clinical Research

Volumn , Issue , 2006, Pages 25-32

  Stötter, Hans ^a  

^a Swissmedic   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52449110548     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000097773     Document Type: Chapter

References (18)

1. 1962 amendment of the Food Drug and Cosmetic Act (FDCA). http://www.mca.gov.uk/aboutagency/regframework/regframework.htm
2. Impicciatore P, Choonara I: Status of new medicines approved by the European Medi-cines Evaluation Agency regarding paediatric use. Br J Clin Pharmacol 1999; 48: 15-18.
3. Conroy S, Choonara I, Impicciatore P, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, t'Jong G, de Hoog M, van den Anker JN: Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000; 320: 79-97.
4. Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg LTW: Lack of ap-propriate formulations of medicines for children in the community. Acta Paediatr 2003; 92: 1486-1489.
5. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C: Incidence of adverse drug reactions in paediatric in/out patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83.
6. Kozer E, Scolnik D, Keays T, Shi K, Luk T, Koren G: Large errors in the dosing of med-icines for children. N Engl J Med 2002; 346: 1175-1176.
7. Choonara I, Rieder MJ: Drug toxicity and adverse drug reactions in children: a brief historical review. Paed Perinatal Drug Ther 2002; 5: 12-18.
8. Harry JW, Keitt AS: Studies on the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia. Br J Haematol 1983; 54: 29-41.
9. Comby HH: Cyanosis in infants caused by nitrates in well water. JAMA 1987; 257: 2788-2792.
10. Geiling EMK, Cannon PR: Pathologic effects of elixir of sulphanilamide (diethylen glycol) poisoning. JAMA 1938; 111: 919-926.
11. Silverman WA, et al: A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956; 18: 614-624.
12. Weiss CF, Glazko AJ, Weston JK: Chloramphenicol in the newborn infant. N Engl J Med 1960; 262: 787-794.
13. Menon PA, Thach BT, Smith CH, Landt M, Roberts JL, Hillmann RE, et al: Benzyl al-cohol toxicity in a neonatal intensive care unit. Am J Perinatol 1984; 1: 288-292.
14. Fisher E, Siemes H, Pund R, Wittfoht W, Nau H: Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal me-tabolite pattern associated with reversible hepatotoxicity. Epilepsia 1992; 33: 165-171.
15. American Academy of Pediatrics: Acetaminophen toxicity in children. Pediatrics 2001; 108: 1020-1024. http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/safetymessages/ssrioverview_101203.htm
16. Brent DA: Antidepressants and pediatric depression: the risk of doing nothing. N Engl J Med 2004; 351: 1598-1601. http://www.fda.gov/cder/pediatric/
17. International Conference on Harmonization ICH: Guideline E11: Clinical investiga-tion of medicinal products in the paediatric population. 19 July 2000. Available from: http://www.emea.eu.int/pdfs/human/ich/271199en.pdf
18. t'Jong GW, Stricker BHCh, Choonara I, van den Anker JN: Lack of effect of the Euro-pean guidance on clinical investigation of medicines in children. Acta Paediatr 2002; 91: 1233-1238.